Tom Mitchell

Tom Mitchell studied medicine at the University of Oxford before training in urology in the East of England (2011–2018). He was awarded Fellowship of the Royal College of Surgeons in 2018. He now practises as a Consultant Urologist at Addenbrooke's Hospital, where he specialises in the surgical management of patients with kidney cancer.

His scientific training includes a DPhil in Engineering Science from the University of Oxford. During his clinical training, he held an Academic Clinical Lectureship at the University of Cambridge (2014–2018). In 2018, he was awarded a Cancer Research UK Clinical Scientist Fellowship at the Wellcome Sanger Institute, prior to becoming a Group Leader at the Early Cancer Institute in 2023.

His group aims to improve outcomes for patients with urological malignancies, by developing clinically useful methods to predict tumour behaviour, and implementing strategies to prevent incurable disease. In October 2024, he was appointed Krishnan-Ang Distinguished Group Leader in the Urological Malignancies Virtual Institute (UMVI). His appointment was funded through a generous donation by the Krishnan-Ang Foundation to Trinity College.